Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Dendreon and Provenge: Too High of a Risk for the Reward
Dendreon and Provenge: Too High of a Risk for the Reward
Dendreon and Provenge: Too High of a Risk for the Reward
Submitted by
admin
on August 15, 2011 - 6:30pm
Source:
Seeking Alpha
News Tags:
prostate cancer
Dendreon
Provenge
JNJ
Headline:
Dendreon and Provenge: Too High of a Risk for the Reward
Do Not Allow Advertisers to Use My Personal information
